← Back to all trials
Active Not Recruiting
NCT03085043
Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer
Conditions: Prostate Carcinoma
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 98
Sponsor: M.D. Anderson Cancer Center
Location: M D Anderson Cancer Center Houston Texas
Summary
This trial studies how well magnetic resonance whole body diffusion-weighted imaging works in finding cancer that has spread to the bone or lymph nodes (metastasis) in participants with high-risk prostate cancer. Diagnostic procedures, such as magnetic resonance whole body diffusion-weighted imaging (a method to show how water moves in a certain area) may help find bone or lymph nodes metastasis.
Eligibility Criteria
Inclusion Criteria:
* Prostate carcinoma patients at high risk for metastasis with prostate-specific antigen (PSA) more than 20 ng/ml and/or Gleason score = 8/ \> 8.
* Ability to understand and sign informed consent.
Exclusion Criteria:
* Patient is at low risk for metastasis with Gleason score at diagnosis \< 8.
* Currently receiving or history of systemic therapy with testosterone suppressing medication (i.e., lupron, degarelix, abiraterone, enzalutamide) or local radiation therapy.
* Contraindication to magnetic resonance imaging (MRI).
Source: ClinicalTrials.gov (NCT03085043). StuddyBuddy aggregates publicly available trial information.
